Stoke Therapeutics, Inc.

Historical 13F Holders

Symbol
STOK
CUSIP
86150R107
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 86150R107 since 12/18/2024, largest first.

Filer % of Class Filed
RTW Investments, LP 13G/A
9.9% 11/16/2026
Event 9/30/2026
FMR LLC 13G/A
7.5% 11/5/2026
Event 9/30/2026
Wellington Management Group LLP 13G/A
7.3% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 6.8% 10/17/2025
Event 9/30/2025
Redmile Group, LLC 13G/A
6.7% 5/15/2026
Event 3/31/2026
Lynx1 Capital Management LP 13G/A
6.5% 8/14/2026
Event 6/30/2026
Biotechnology Value Fund L P 13G
5.6% 9/30/2026
Event 9/23/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Morgan Stanley 13G/A
4.9% 11/13/2026
Event 9/30/2026
Toronto Dominion Bank 13G/A
4.9% 8/12/2026
Event 6/30/2026
Baker Bros. Advisors LP 13G/A
4.7% 11/16/2026
Event 9/30/2026
BlackRock Portfolio Management LLC 13G/A 4.7% 7/15/2025
Event 6/30/2025
Skorpios Trust 13D/A
4.1% 8/26/2025
Event 8/22/2025
Cowen Financial Products LLC 13G/A 0% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 185 73.7 M $1.92B
2026 Q2 198 76.2 M $2.49B
2026 Q1 198 71.1 M $2.31B
2025 Q4 186 67.0 M $2.13B
2025 Q3 154 67.7 M $1.57B
2025 Q2 135 65.5 M $744M
2025 Q1 127 63.4 M $422M
2024 Q4 131 58.1 M $640M
2024 Q3 120 58.2 M $715M
2024 Q2 117 61.3 M $829M
2024 Q1 107 54.2 M $732M
2023 Q4 82 45.0 M $237M
2023 Q3 99 43.9 M $173M
2023 Q2 101 46.5 M $495M
2023 Q1 98 44.6 M $372M
2022 Q4 108 40.3 M $372M
2022 Q3 108 42.3 M $544M
2022 Q2 96 43.1 M $569M
2022 Q1 102 41.4 M $871M
2021 Q4 96 35.4 M $855M
2021 Q3 90 19.4 M $492M
2021 Q2 98 20.2 M $680M
2021 Q1 107 38.4 M $1.49B
2020 Q4 96 38.6 M $2.39B
2020 Q3 90 34.6 M $1.16B
2020 Q2 72 34.9 M $825M
2020 Q1 68 34.6 M $791M
2019 Q4 65 33.5 M $948M
2019 Q3 54 15.9 M $339M
2019 Q2 48 14.2 M $409M